Exane Derivatives’s Booz Allen Hamilton BAH Stock Holding History

Exane Derivatives’s Portfolio BAH Stock Details BAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	-$351	–	798
2022 Q1	$351	Hold	4	–	–	﹤0.01%	906
2021 Q4	$339	Sell	4 -56	-93%	-$4.72K	﹤0.01%	807
2021 Q3	$4.76K	Sell	60 -948	-94%	-$79.2K	﹤0.01%	743
2021 Q2	$89.5K	Buy	+1,008	New	+$85.2K	0.02%	556
2021 Q1	–	Sell	-28	Closed	-$2.44K	–	918
2020 Q4	$2.44K	Sell	28 -5,827	-100%	-$496K	﹤0.01%	608
2020 Q3	$486K	Buy	5,855 +140	+2%	+$11.5K	0.14%	134
2020 Q2	$445K	Buy	+5,715	New	+$432K	0.12%	152

Other funds holding BAH

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exane Derivatives's BAH Position: Q2 2022 in Review

Exane Derivatives sold out of Booz Allen Hamilton (BAH) in Q2 2022, closing a stake of 4 shares — an estimated $351 sold.

Exane Derivatives first reported a position in BAH in Q2 2020 and held it in 7 quarters. The position peaked at $486K in Q3 2020. 539 funds tracked by Wall St. Rank hold BAH as of Q2 2022.

Exane Derivatives reported no remaining Booz Allen Hamilton position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 4 Booz Allen Hamilton shares in Q2 2022, an estimated $351.
Exane Derivatives first reported a position in Booz Allen Hamilton in Q2 2020 and held it in 7 quarters.
Exane Derivatives's Booz Allen Hamilton position peaked at $486K in Q3 2020.
539 funds tracked by Wall St. Rank held Booz Allen Hamilton as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.